Noxopharm Secures A$2.1M Convertible Notes Investment
Company Announcements

Noxopharm Secures A$2.1M Convertible Notes Investment

Noxopharm Ltd. (AU:NOX) has released an update.

Noxopharm Limited has announced the issuance of A$2.1 million in convertible notes to sophisticated investors, aimed at providing funding for the company to pursue potential opportunities without immediate financial pressure. The notes come with a 12% interest rate and options for investors, plus an additional potential A$500,000 investment from the company’s chairman pending shareholder approval. This move is part of Noxopharm’s strategy to progress in developing novel cancer and inflammation treatments, as well as enhancing mRNA vaccine technology.

For further insights into AU:NOX stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App